
---
title: '康恩贝：子公司挂牌转让迪耳药业25%股权'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=4497'
author: 证券时报网
comments: false
date: Mon, 29 Nov 2021 17:36:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=4497'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="http://info.stcn.com/dc/stock/?stockcode=SS600572" style="color: #2f67d1;text-decoration: none;" code="600572" target="_blank">康恩贝</a>(600572)11月29日晚间公告，为聚焦发展中药大健康产业核心业务，及时处置低效资产、回笼资金，控股子公司金华<a class="trsHotWords" href="http://info.stcn.com/dc/stock/?stockcode=SS600572" style="color: #2f67d1;text-decoration: none;" code="600572" target="_blank">康恩贝</a>拟公开挂牌转让迪耳药业25%股权，挂牌价不低于3974.72万元。</p>

                  
</div>
            